Lidbree

Lidocaine, the active ingredient in Lidbree, is a local anesthetic presented as a sterile solution for intrauterine use. It provides temporary loss of sensation during intrauterine procedures and is administered by qualified health professionals. Lidbree is indicated for procedures that require localized uterine anesthesia.

GNH USA supplies Lidbree as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine is a local anesthetic used in intrauterine procedures to achieve temporary loss of sensation.

- Intrauterine procedures: provides local anesthesia during hysteroscopic surgery, endometrial ablation, and intrauterine device placement. - Diagnostic hysteroscopy: facilitates patient comfort while allowing detailed uterine evaluation. - Therapeutic uterine interventions: enables pain control for operative procedures such as polypectomy or myomectomy.

Lidocaine administered intrauterinely may cause a range of adverse reactions.

Common Side Effects: - Uterine cramping: mild to moderate discomfort during or after administration. - Vaginal bleeding: transient spotting or light bleeding. - Nausea: occasional mild nausea. - Headache: brief headache episodes. - Dizziness: transient light‑headedness. - Local irritation: mild irritation at the application site.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or anaphylaxis. - Severe hypotension: sudden drop in blood pressure. - Cardiac arrhythmia: irregular heart rhythm. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Central nervous system toxicity: seizures or altered mental status. - Persistent uterine pain: prolonged severe pain requiring medical attention.

Lidbree should be used with careful consideration of patient‑specific factors and handling requirements.

- Pregnancy: safety not established; avoid unless essential. - Breastfeeding: unknown safety; weigh potential risks. - Allergy: contraindicated in patients with known lidocaine hypersensitivity. - Cardiovascular disease: use with caution; monitor heart rate and blood pressure. - Storage: Store below 25°C: keep in original container, protect from light and moisture.

Lidbree may interact with other medications that affect cardiac or metabolic pathways.

Major Interactions (Avoid): - Class I antiarrhythmic drugs (e.g., quinidine, procainamide): additive cardiotoxicity. - Beta‑blockers: may enhance bradycardia. - CYP3A4 inhibitors (e.g., ketoconazole): increase lidocaine plasma levels.

Moderate Interactions (Monitor Closely): - CYP1A2 inducers (e.g., rifampin): may reduce lidocaine efficacy. - Concurrent local anesthetics: risk of cumulative toxicity. - General anesthetics: potential potentiation of central nervous system depression.